{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:47:34Z","timestamp":1792097254499,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","award":["2024FY06"],"award-info":[{"award-number":["2024FY06"]}],"id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1\\u2013003"],"award-info":[{"award-number":["2021-I2M-1\\u2013003"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["T-B-106"],"award-info":[{"award-number":["T-B-106"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2025-I2M-KJ-027"],"award-info":[{"award-number":["2025-I2M-KJ-027"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.canlet.2025.218210","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:24:06Z","timestamp":1765931046000},"page":"218210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["lncDDR suppresses drug resistance by regulating DNA damage repair through ILF2-YB1 in T-cell acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"639","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9412-8798","authenticated-orcid":false,"given":"Kegan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyu","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2536-4180","authenticated-orcid":false,"given":"Zhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10230","key":"10.1016\/j.canlet.2025.218210_bib1","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.canlet.2025.218210_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094502","article-title":"The new therapeutic strategies in pediatric T-Cell acute lymphoblastic leukemia","volume":"22","author":"Lato","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.canlet.2025.218210_bib3","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/ijc.34819","article-title":"The landscape of alterations affecting epigenetic regulators in T-cell acute lymphoblastic leukemia: roles in leukemogenesis and therapeutic opportunities","volume":"154","author":"Walia","year":"2024","journal-title":"Int. J. Cancer"},{"issue":"36","key":"10.1016\/j.canlet.2025.218210_bib4","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1200\/JCO.23.01286","article-title":"Advancing diagnostics and therapy to reach universal cure in childhood ALL","volume":"41","author":"Pieters","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2025.218210_bib5","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/ajh.27708","article-title":"Adult acute lymphoblastic leukemia: 2025 update on diagnosis, therapy, and monitoring","volume":"100","author":"Kantarjian","year":"2025","journal-title":"Am. J. Hematol."},{"issue":"14","key":"10.1016\/j.canlet.2025.218210_bib6","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood.2023022920","article-title":"Classification and risk stratification in T-lineage acute lymphoblastic leukemia","volume":"145","author":"Polonen","year":"2025","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.canlet.2025.218210_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41576-024-00761-7","article-title":"Chromosomal instability as a driver of cancer progression","volume":"26","author":"Chen","year":"2025","journal-title":"Nat. Rev. Genet."},{"issue":"2","key":"10.1016\/j.canlet.2025.218210_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","article-title":"Targeting DNA damage response pathways in cancer","volume":"23","author":"Groelly","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.canlet.2025.218210_bib9","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.molcel.2022.05.004","article-title":"Hallmarks of DNA replication stress","volume":"82","author":"Saxena","year":"2022","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.canlet.2025.218210_bib10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41580-024-00775-3","article-title":"Roles of chromatin and genome instability in cellular senescence and their relevance to ageing and related diseases","volume":"25","author":"Wu","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.canlet.2025.218210_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2024.100030","article-title":"Cell cycle dysregulation in cancer","volume":"77","author":"Glaviano","year":"2025","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.canlet.2025.218210_bib12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s43587-025-00827-z","article-title":"The complex interplay between aging and cancer","volume":"5","author":"Trastus","year":"2025","journal-title":"Nat. Aging"},{"issue":"4","key":"10.1016\/j.canlet.2025.218210_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.01.002","article-title":"Endogenous DNA damage as a source of genomic instability in cancer","volume":"168","author":"Tubbs","year":"2017","journal-title":"Cell"},{"issue":"5\u20136","key":"10.1016\/j.canlet.2025.218210_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1101\/gad.349431.122","article-title":"DNA repair defects in cancer and therapeutic opportunities","volume":"36","author":"Hopkins","year":"2022","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.canlet.2025.218210_bib15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41571-024-00923-w","article-title":"Targeting chromosomal instability in patients with cancer","volume":"21","author":"Al-Rawi","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.canlet.2025.218210_bib16","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","article-title":"Integrated lncRNA function upon genomic and epigenomic regulation","volume":"82","author":"Herman","year":"2022","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.canlet.2025.218210_bib17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41580-023-00694-9","article-title":"Transcription regulation by long non-coding RNAs: mechanisms and disease relevance","volume":"25","author":"Ferrer","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.canlet.2025.218210_bib18","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1080\/10428194.2017.1397662","article-title":"Drugging DNA repair to target T-ALL cells","volume":"59","author":"Dasgupta","year":"2018","journal-title":"Leuk. Lymphoma"},{"issue":"21","key":"10.1016\/j.canlet.2025.218210_bib19","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2217\/fon-2020-1072","article-title":"Inhibition of DNA damage response pathway using combination of DDR pathway inhibitors and radiation in treatment of acute lymphoblastic leukemia cells","volume":"17","author":"Katoueezadeh","year":"2021","journal-title":"Future Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2025.218210_bib20","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.canlet.2025.218210_bib21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","article-title":"The genetics and molecular biology of T-ALL","volume":"129","author":"Girardi","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.canlet.2025.218210_bib22","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1038\/s12276-024-01335-7","article-title":"Cells and signals of the leukemic microenvironment that support progression of T-cell acute lymphoblastic leukemia (T-ALL)","volume":"56","author":"Lyu","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.canlet.2025.218210_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s40246-023-00531-2","article-title":"RUN(X) out of blood: emerging RUNX1 functions beyond hematopoiesis and links to Down syndrome","volume":"17","author":"Rozen","year":"2023","journal-title":"Hum. Genom."},{"issue":"10","key":"10.1016\/j.canlet.2025.218210_bib24","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1038\/s41375-018-0110-4","article-title":"Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia","volume":"32","author":"Ngoc","year":"2018","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.canlet.2025.218210_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.yexcr.2004.12.030","article-title":"NF45\/ILF2 tissue expression, promoter analysis, and interleukin-2 transactivating function","volume":"305","author":"Zhao","year":"2005","journal-title":"Exp. Cell Res."},{"issue":"23","key":"10.1016\/j.canlet.2025.218210_bib26","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1128\/MCB.05849-11","article-title":"The NF90\/NF45 complex participates in DNA break repair via nonhomologous end joining","volume":"31","author":"Shamanna","year":"2011","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.canlet.2025.218210_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ccell.2017.05.011","article-title":"ILF2 is a regulator of RNA splicing and DNA damage response in 1q21-Amplified multiple myeloma","volume":"32","author":"Marchesini","year":"2017","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.canlet.2025.218210_bib28","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1093\/nar\/gkaa127","article-title":"Long noncoding RNA HCP5 participates in premature ovarian insufficiency by transcriptionally regulating MSH5 and DNA damage repair via YB1","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.canlet.2025.218210_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41573-024-01060-w","article-title":"DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications","volume":"24","author":"Drew","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.canlet.2025.218210_bib30","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1001\/jamaoncol.2024.2185","article-title":"And associated cancer risks and management for Male patients A review","volume":"10","author":"Cheng","year":"2024","journal-title":"JAMA Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2025.218210_bib31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/humupd\/dmac038","article-title":"Contraceptives and cancer risks in BRCA1\/2 pathogenic variant carriers: a systematic review and meta-analysis","volume":"29","author":"van Bommel","year":"2023","journal-title":"Hum. Reprod. Update"},{"issue":"14","key":"10.1016\/j.canlet.2025.218210_bib32","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian cancer: a review","volume":"334","author":"Caruso","year":"2025","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.canlet.2025.218210_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/jir.1998.18.351","article-title":"Mapping interleukin enhancer binding factor 3 gene (ILF3) to human chromosome 19 (19q11-qter and 19p11-p13.1) by polymerase chain reaction amplification of human-rodent somatic cell hybrid DNA templates","volume":"18","author":"Marcoulatos","year":"1998","journal-title":"J. Interferon Cytokine Res."},{"issue":"6","key":"10.1016\/j.canlet.2025.218210_bib34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nchembio.939","article-title":"Synthetic oligonucleotides recruit ILF2\/3 to RNA transcripts to modulate splicing","volume":"8","author":"Rigo","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"20","key":"10.1016\/j.canlet.2025.218210_bib35","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1128\/MCB.00306-15","article-title":"The NF45\/NF90 heterodimer contributes to the biogenesis of 60S ribosomal subunits and influences nucleolar morphology","volume":"35","author":"Wandrey","year":"2015","journal-title":"Mol. Cell Biol."},{"issue":"13","key":"10.1016\/j.canlet.2025.218210_bib36","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1158\/0008-5472.CAN-20-4160","article-title":"Nicotine-Induced ILF2 facilitates nuclear mRNA export of pluripotency factors to promote stemness and chemoresistance in human esophageal cancer","volume":"81","author":"Li","year":"2021","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.canlet.2025.218210_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107660","article-title":"NF45 and NF90 regulate mitotic gene expression by competing with staufen-mediated mRNA decay","volume":"31","author":"Nourreddine","year":"2020","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.canlet.2025.218210_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13697","article-title":"Single-cell RNA sequencing elucidated the landscape of breast cancer brain metastases and identified ILF2 as a potential therapeutic target","volume":"57","author":"Xie","year":"2024","journal-title":"Cell Prolif."},{"key":"10.1016\/j.canlet.2025.218210_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1513979","article-title":"ILF2: a multifaceted regulator in malignant tumors and its prospects as a biomarker and therapeutic target","volume":"14","author":"Sun","year":"2024","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2025.218210_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076258","article-title":"NUSAP1 binds ILF2 to modulate R-Loop accumulation and DNA damage in prostate cancer","volume":"24","author":"Chiu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.canlet.2025.218210_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119157","article-title":"LncRNA regulates breast cancer DNA damage response and sensitivity to PARP inhibitors via binding to ILF2","volume":"24","author":"Zhao","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.canlet.2025.218210_bib42","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41467-024-45350-8","article-title":"Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma","volume":"15","author":"Thongon","year":"2024","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.canlet.2025.218210_bib43","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.4161\/cc.26670","article-title":"The proteolytic YB-1 fragment interacts with DNA repair machinery and enhances survival during DNA damaging stress","volume":"12","author":"Kim","year":"2013","journal-title":"Cell Cycle"},{"issue":"18","key":"10.1016\/j.canlet.2025.218210_bib44","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1038\/sj.onc.1206357","article-title":"Nuclear localization of Y-box factor YB1 requires wild-type p53","volume":"22","author":"Zhang","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2025.218210_bib45","doi-asserted-by":"crossref","first-page":"8087","DOI":"10.1038\/s41598-023-35220-6","article-title":"YB1 modulates the DNA damage response in medulloblastoma","volume":"13","author":"McSwain","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.218210_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-2253-6_1","article-title":"Visualization of lncRNA by single-molecule fluorescence in situ hybridization","volume":"1262","author":"Dunagin","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.canlet.2025.218210_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/0471142905.hg0415s76","article-title":"A multifaceted FISH approach to study endogenous RNAs and DNAs in native nuclear and cell structures","author":"Byron","year":"2013","journal-title":"Curr Protoc Hum Genet"},{"issue":"113","key":"10.1016\/j.canlet.2025.218210_bib48","doi-asserted-by":"crossref","DOI":"10.3791\/54207","article-title":"Detection of RNA-binding proteins by in vitro RNA pull-down in adipocyte culture","author":"Bai","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.canlet.2025.218210_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4939-6380-5_7","article-title":"RIP: RNA immunoprecipitation","volume":"1480","author":"Gagliardi","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.canlet.2025.218210_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-4939-3591-8_2","article-title":"Identification of mRNA-Interacting factors by MS2-TRAP (MS2-Tagged RNA affinity purification)","volume":"1421","author":"Yoon","year":"2016","journal-title":"Methods Mol. Biol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525007827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525007827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:36:30Z","timestamp":1792096590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525007827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":50,"alternative-id":["S0304383525007827"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.218210","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"lncDDR suppresses drug resistance by regulating DNA damage repair through ILF2-YB1 in T-cell acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.218210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218210"}}